With regard to using US manufacturing facilities for Leronlimab, PRs about manufacturing LL were released in 2020 by US manufacturers. I don’t know if there are any current agreements, but it can be done if needed to qualify for a Commissioner’s National Priority Voucher.

AGC Biologics (Seattle) for manufacturing make the drug.

https://www.agcbio.com/hs-search-results?term=CytoDyn


Ajinomoto Althea (San Diego) for aseptic fill-finish.

https://www.ajibio-pharma.com/news-post/ajino...al-trials/


Note: PCI Pharma Services purchased Ajinomoto Althea on 5/1/25.

https://pci.com/pci-pharma-services-completes...to-althea/